Insulin analogues versus human insulin in type 1 diabetes: direct and indirect meta-analyses of efficacy and safety

Conegero Sanches, A. C., Correr, C. J., Venson, R. , Rodrigues Gonçalves, P., Martins Garcia, M., Piantavini, M. S. and Pontarolo, R. (2013) Insulin analogues versus human insulin in type 1 diabetes: direct and indirect meta-analyses of efficacy and safety. Brazilian Journal of Pharmaceutical Sciences, 49(3), pp. 501-509. (doi: 10.1590/s1984-82502013000300011)

[img]
Preview
Text
178514.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

1MB

Abstract

All patients with Diabetes Mellitus (DM) receive insulin therapy. In this study, we evaluated the efficacy, safety and tolerability of human insulin and insulin analogues. We performed a systematic review of the literature and a meta-analysis according to the Cochrane Collaboration methodology. In the absence of clinical studies comparing insulins, we performed a mixed treatment comparison to establish the differences between the active treatments. We included studies published from 1995 to 2010. HbA1c results, episodes of hypoglycemia and nocturnal hypoglycemia data were extracted and analyzed. Thirty-five randomized clinical trials were selected after examining the abstract and a full text review. These studies included 4,206 patients who received long-acting insulin analogues and 5,733 patients who received short-acting insulin analogues. Pooled data regarding efficacy indicated no significant differences in HbA1c values between glargine or detemir (once daily) and NPH insulin. However, a twice-daily dose of detemir produced differences in HbA1c values that favored detemir (-0.14% [95% CI: -0.21 to -0.08]; p<0.0001; I2=0%). Direct and indirect comparisons are consistent and show that there were no significant differences between human insulin and insulin analogues in efficacy or safety. Our results indicate that long- and short-acting insulin analogues offer few clinical advantages over conventional human insulin.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Venson, Dr Rafael
Authors: Conegero Sanches, A. C., Correr, C. J., Venson, R., Rodrigues Gonçalves, P., Martins Garcia, M., Piantavini, M. S., and Pontarolo, R.
Subjects:R Medicine > R Medicine (General)
R Medicine > RM Therapeutics. Pharmacology
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology Assessment
Journal Name:Brazilian Journal of Pharmaceutical Sciences
Publisher:Universidade de São Paulo
ISSN:1984-8250
ISSN (Online):2175-9790
Copyright Holders:Copyright © 2013 The Authors
First Published:First published in Brazilian Journal of Pharmaceutical Sciences 49(3): 501-509
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record